STERIS plc (Ireland) (STE) Q2 2026 earnings — TrendMatrix coverage

Reported EPS

$2.59

Estimate

$2.49

Surprise

+3.9%

Score at report (before → after)

6.2 → 6.1/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

STERIS plc (Ireland) (STE) beat the $2.49 estimate with diluted EPS of $2.59 — a clear 3.9% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.2/10) to Hold at 6.1/10 after the report — the engine's score fell despite the beat.

TrendMatrix currently rates STE Hold at 5.2/10.

2 of the last 4 quarters beat the estimate; this quarter's +3.9% surprise compares with a +2.0% four-quarter average. Next scheduled report: 2026-11-04.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$225.31

Price target

$228.92

Stop

$215.19

Upside to target

+1.6%

Reward-to-risk

0.3:1

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Devices

Market cap

$22.12B

P/E (fwd)

18.5

P/E (ttm)

28.2

52-week range

$195.14–$269.44

Off 52-week high

16.4%

RSI (14)

42

Volume vs avg

0.32×

Score today

5.2/10